Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study published in Osteoarthritis and Cartilage Open could help improve the lives of people at risk of developing knee osteoarthritis.

A doctor treats a patient with knee osteoarthritis

A new study by researchers in Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) has identified a link between ankle pain and the onset of symptoms of knee osteoarthritis (OA).

"Foot and ankle symptoms are very common among middle-aged and older adults, and isolated joint pain in OA is uncommon," said Dr Thomas Perry, lead author of the study and Postdoctoral Researcher in molecular pathogenesis of osteoarthritis pain at NDORMS. "Although it has been established that symptoms and/or structural OA in lower extremity joints (e.g., ankle) can affect other kinematically involved joints such as the knee, there is little data describing the relationship between the ankle/foot and incident knee OA outcomes."

Using data from the Multicentre Osteoarthritis Study (MOST), the researchers examined the relationship between three symptoms; ankle pain, foot pain, and ankle and foot pain, and different knee outcomes.

Read the full story on the NDORMS website

Similar stories

Oxford University wins prestigious Queen’s Anniversary Prize

Her Majesty The Queen has approved the award of The Queen’s Anniversary Prizes to twenty-one higher and further education institutions, including Oxford University, in the most recent round of the independently reviewed scheme. This prestigious award is the highest national honour available to universities and FE colleges across the UK.

Jenner Institute named Covid Innovation Heroes

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.